Stromal expression of CD34, α-smooth muscle actin and CD26/DPPIV in squamous cell carcinoma of the skin: A comparative immunohistochemical study

Pathology and Oncology Research

Volumn 18, Issue 1, 2012, Pages 25-31

  Kacar, Ayper ^a   Arikok, Ata Türker ^b   Kokenek Unal, Tuba Dilay ^b   Onder, Evrim ^b   Hucumenoglu, Sema ^c   Alper, Murat ^b  

^a ANKARA ONCOLOGY HOSPITAL   (Turkey)

^b DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c Etlik Ihtisas Training and Research Hospital   (Turkey)

Author keywords

SMA; CD26; CD34; Squamous cell carcinoma; Tumor stroma

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD34 ANTIGEN; DIPEPTIDYL PEPTIDASE IV;

ACTINIC ELASTOSIS; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CELL TYPE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ELASTOSIS; FEMALE; FIBROCYTE; GENE PRODUCT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; KERATOACANTHOMA; MALE; MYOFIBROBLAST; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; SEBORRHEIC KERATOSIS; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; STROMA; TUMOR SUPPRESSOR GENE;

ACTINS; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD34; CARCINOMA, SQUAMOUS CELL; DIPEPTIDYL PEPTIDASE 4; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATOACANTHOMA; KERATOSIS, SEBORRHEIC; MALE; MIDDLE AGED; SKIN NEOPLASMS; STATISTICS, NONPARAMETRIC; STROMAL CELLS;

EID: 84855276889     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-011-9412-9     Document Type: Article

References (39)

1. N Kojc N Zidar B Vodopivec, et al. 2005 Expression of CD 34, alpha-smooth muscle actin, and transforming growth factor beta-1 in squamous intraepithelial lesions and squamous cell carcinoma of larynx and hypopharynx Hum Pathol 36 1 16 21 15712177 10.1016/j.humpath.2004.10.011 1:CAS:528:DC%2BD2MXhtlemu78%3D (Pubitemid 40215629)
2. JA Parrott E Nilsson R Mosher, et al. 2001 Stromal epithelial interaction in the progression of the ovarian cancer: influence and source of tumor stromal cells Mol Cell Endocrinol 175 29 39 11325514 10.1016/S0303-7207(01)00436-1 1:CAS:528:DC%2BD3MXivFeisbk%3D (Pubitemid 32372541)
3. HF Dvorak 1986 Tumors: wounds that do not heal N Engl J Med 315 1650 1659 3537791 10.1056/NEJM198612253152606 1:STN:280:DyaL2s%2FmsV2mtw%3D%3D
4. PJ Barth TS Zu Schweinsberg A Ramaswamy R Moll 2004 CD 34 + fibrocytes, alpha-smooth muscle antigen-positive myofibroblasts, and CD 117 expression in the stroma of invasive squamous cell carcinomas of the oral cavity pharynx and larynx Virchows Arch 444 3 231 234 14758552 10.1007/s00428-003-0965-1 1:CAS:528:DC%2BD2cXitFWrtrw%3D (Pubitemid 38446434)
5. PJ Barth S Ebrahimsade A Hellinger, et al. 2002 CD34+ fibrocytes in neoplastic and inflammatory pancreatic lesions Virchows Arch 440 128 133 11964041 10.1007/s00428-001-0551-3 1:CAS:528:DC%2BD38XhtF2iur8%3D (Pubitemid 34169848)
6. PJ Barth S Ebrahimsade A Ramaswamy, et al. 2002 CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign lesions Virchows Arch 440 298 303 11889601 10.1007/s004280100530 1:CAS:528:DC%2BD38Xhsleksb4%3D (Pubitemid 34230735)
7. PJ Barth A Ramaswamy R Moll, et al. 2002 CD34+ fibrocytes in normal cervical stroma, cervical intraepithelial neoplasia III, and invasive squamous cell carcinoma of the cervix uteri Virchows Arch 441 564 568 12461613 10.1007/s00428-002-0713-y (Pubitemid 35435826)
8. H Chauhan A Abraham JR Philips, et al. 2003 There is more than one kind of myofibroblast: analysis of CD34 expression in benign, in situ, and invasive breast lesions J Clin Pathol 56 271 276 12663638 10.1136/jcp.56.4.271 1:STN:280:DC%2BD3s7nslKhug%3D%3D (Pubitemid 36459796)
9. TT Kirchmann VG Pietro BR Smoller 1994 CD34 staining pattern distinguishes basal cell carcinoma from trichoepithelioma Arch Dermatol 130 589 592 7513986 10.1001/archderm.1994.01690050057008 1:STN:280:DyaK2c3jsVOgtw%3D%3D (Pubitemid 24150937)
10. A Ramaswamy R Moll PJ Barth 2003 CD34+ fibrocytes in tubular carcinomas and radical scars of the breast Virchows Arch 443 536 540 12898244 10.1007/s00428-003-0855-6 (Pubitemid 37363381)
11. PA Havre M Abe Y Urasaki, et al. 2008 The role of CD26/dipeptidyl peptidase IV in cancer Front Biosci 13 1634 1645 17981655 10.2741/2787 1:CAS:528:DC%2BD1cXhs1CgsLY%3D (Pubitemid 351599721)
12. AM Lambeir C Durinks S Scharpe I De Meester 2003 Dipeptidyl-peptidase IV from bench to bedside; an update on structural properties, functions, and clinical aspects of the enzyme DPP IV Crit Rev Clin Lab Sci 40 3 209 294 12892317 10.1080/713609354 1:CAS:528:DC%2BD3sXmtVWhs70%3D (Pubitemid 36775376)
13. MA Lima VA Gontijo FCL Schmitt 1998 CD26 (dipeptidyl aminopeptidase IV) expression in normal and diseased human thyroid glands Endocr Pathol 9 43 52 12114661 10.1007/BF02739951 1:CAS:528:DyaK1cXks1ems7o%3D (Pubitemid 28304405)
14. H Kajiyama K Shibata M Terauchi, et al. 2006 Involvement of DPPIV/CD26 in epithelial morphology and suppressed invasive ability in ovarian carcinoma cells Ann N Y Acad Sci 1086 233 240 17185520 10.1196/annals.1377.007 1:CAS:528:DC%2BD2sXhtVWhtbs%3D (Pubitemid 47084375)
15. T Tanaka K Umeki I Yamamoto, et al. 1995 CD26 (dipeptidyl peptidase IV/DPP IV) as a novel molecular marker for differentiated thyroid carcinoma Int J Cancer 64 326 331 7591305 10.1002/ijc.2910640508 1:STN:280: DyaK28%2Fkt1Kmtg%3D%3D
16. MJ Wilson AR Ruhrland BJ Quast, et al. 2000 Dipeptidyl peptidase IV activities are elevated in prostate cancers and adjacent benign hyperplastic glands J Androl 21 220 226 10714816 1:CAS:528:DC%2BD3cXhvFGhtro%3D (Pubitemid 30123703)
17. F Kikkawa H Kajiyama K Shibata, et al. 2005 Dipeptidyl peptidase in tumor progression Biochim Biophys Acta 1751 45 51 16054016 1:CAS:528: DC%2BD2MXmvVWmu7Y%3D
18. UV Wesley AP Albino S Tiwari, et al. 1999 A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells J Exp Med 190 311 322 10430620 10.1084/jem.190.3.311 1:CAS:528:DyaK1MXkvFarsro%3D (Pubitemid 29374829)
19. MC Moehrle BE Schlagenhauff C Klessen, et al. 1995 Aminopeptidase M and dipeptidyl peptidase IV activity in epithelial skin tumours: a histochemical study J Cutan Pathol 22 3 241 247 7593818 10.1111/j.1600-0560.1995.tb00745.x 1:STN:280:DyaK28%2Fot1alsQ%3D%3D
20. MA Goscinski ZH Suo JM Nesland, et al. 2008 Dipeptidyl peptidase IV expression in cancer and stromal cells of human esophageal cell carcinomas, adenocarcinomas and squamous cell carcinoma cell lines APMIS 116 823 831 19024603 10.1111/j.1600-0463.2008.01029.x 1:CAS:528:DC%2BD1cXhtlGlu77K
21. S Tsuzuki H Ota M Hayama, et al. 2001 Proliferation of α-smooth muscle actin-containing stromal cells (myofibroblasts) in the lamina propria subjacent to intraepithelial carcinoma of the esophagus Scand J Gastroenterol 36 1 86 91 11218244 10.1080/00365520150218101 1:STN:280:DC%2BD3M3ksVChsA%3D%3D (Pubitemid 32147186)
22. EM Zeisberg S Potenta L Xie, et al. 2007 Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts Cancer Res 67 21 10123 10128 17974953 10.1158/0008-5472.CAN-07-3127 1:CAS:528:DC%2BD2sXht1erur7N (Pubitemid 350070783)
23. H Ohtani 1998 Stromal reaction in cancer tissue: pathophysiologic significance of matrix degrading enzymes in relation to matrix turnover and immune/inflammatory reaction Pathol Int 48 1 9 9589457 10.1111/j.1440-1827.1998. tb03820.x 1:CAS:528:DyaK1cXjtVGks7o%3D (Pubitemid 28204701)
24. SM Pupa S Menard S Forti, et al. 2002 New insights into the role of extracellular matrix during tumour onset and progression J Cell Physiol 192 259 267 12124771 10.1002/jcp.10142 1:CAS:528:DC%2BD38XlvFertb8%3D (Pubitemid 34827603)
25. R Kalluri M Zeisberg 2006 Fibroblasts in cancer Nat Rev Cancer 6 392 401 16572188 10.1038/nrc1877 1:CAS:528:DC%2BD28XjslGitLw%3D
26. G Gabbiani 1998 The cellular derivation and the life span of the myofibroblast Pathol Res Pract 192 708 711 10.1016/S0344-0338(96)80092-6
27. D Ruiter T Bogenrieder D Elder, et al. 2002 Melanoma-stroma interactions: structural and functional aspects Lancet Oncol 3 35 43 11905603 10.1016/S1470-2045(01)00620-9 1:CAS:528:DC%2BD38Xhtleitb8%3D (Pubitemid 34121144)
28. F Bermpohl K Löster W Reutter, et al. 1998 Rat dipeptidyl peptidase IV (DPP IV) exhibits endopeptidase activity with specificity for denatured fibrillar collagens FEBS Lett 428 3 152 156 9654125 10.1016/S0014-5793(98)00515- 8 1:CAS:528:DyaK1cXjt1Cmurs%3D (Pubitemid 28319675)
29. G Ghersi H Dong LA Goldstein, et al. 2002 Regulation of fibroblast migration on collagenous matrix by a cell surface peptidase complex J Biol Chem 277 32 29231 29241 12023964 10.1074/jbc.M202770200 1:CAS:528: DC%2BD38XmsVKjsbg%3D
30. JJ Van den Oord 1998 Expression of CD26/dipeptidyl-petidase IV in benign and malignant pigment-cell lesions of the skin Br J Dermatol 138 4 615 621 9640365 10.1046/j.1365-2133.1998.02171.x (Pubitemid 28212244)
31. B Bauvois 1988 A collagen-binding glycoprotein on the surface of mouse fibroblasts is identified as dipeptidyl peptidase IV Biochem J 252 723 731 2901831 1:CAS:528:DyaL1cXkt1Slsb0%3D
32. K Löster K Zeilinger D Schuppan 1995 The cysteine rich region of dipeptidyl peptidase IV (CD26) is the collagen binding site Biochem Biophys Res Commun 217 1 341 348 8526932 10.1006/bbrc.1995.2782 (Pubitemid 26004797)
33. GA Piazza HM Callanan J Mowery, et al. 1989 Evidence for a role of dipeptidyl peptidase IV in fibronectin-mediated interactions of hepatocytes with extracellular matrix Biochem J 262 327 334 2573346 1:CAS:528:DyaL1MXltlWgu7s%3D (Pubitemid 19220964)
34. W-T Chen 1992 Membrane proteases: role in tissue remodelling and tumor invasion Curr Opin Cell Biol 4 802 809 1419057 10.1016/0955-0674(92)90103-J 1:CAS:528:DyaK3sXhvVyksL8%3D
35. A Thielitz RW Vetter B Schultze, et al. 2008 Inhibitors of dipeptidyl peptidase IV-like activity mediate antifibrotic effects in normal and keloid derived skin fibroblasts J Invest Dermatol 128 4 855 866 17943180 10.1038/sj.jid.5701104 1:CAS:528:DC%2BD1cXjtFOms74%3D (Pubitemid 351374300)
36. XM Wang DM Yu GW McCaughan, et al. 2006 Extra-enzymatic roles of DPIV and FAP in cell adhesion and migration on collagen and fibronectin Adv Exp Med Biol 575 213 222 16700525 10.1007/0-387-32824-6-23 1:CAS:528:DC%2BD1MXpvFOgsg%3D%3D
37. MM Jost J Lamerz H Tammen, et al. 2009 Dipeptidyl peptidase 4 (DPP4) inhibitors represent a novel class of oral anti-hyperglycemic agents. The complete pharmacological profile of these proteases Biochem Pharmacol 77 2 228 237 18940185 10.1016/j.bcp.2008.09.032 1:CAS:528:DC%2BD1cXhsV2lt7vF
38. TB Campbell G Hangoc Y Liu, et al. 2007 Inhibition of CD26 in human cord blood CD34+ cells enhances their engraftment of nonobese diabetic/severe combined immunodeficiency mice Stem Cells Dev 16 3 347 354 17610364 10.1089/scd.2007.9995 1:CAS:528:DC%2BD2sXnt1Wltrg%3D (Pubitemid 47016219)
39. G Ghersi Q Zhao M Salamone Y Yeh 2006 The protease complex consisting of dipeptidyl peptidase IV and seprase plays a role in the migration and invasion of human endothelial cells in collagenous matrices Cancer Res 66 9 4652 4661 16651416 10.1158/0008-5472.CAN-05-1245 1:CAS:528:DC%2BD28XjvF2ksbw%3D